Atara Biotherapeutics Inc ECTRIMS Conference Call Transcript
Ladies and gentlemen, thank you for standing by and welcome to the Atara Biotherapeutics ECTRIMS Conference Call. (Operator Instructions) Please be advised that today's conference may be recorded. (Operator Instructions)
I would now like to hand the conference over to your speaker today, John Craighead, Vice President of Investor Relations and Corporate Communications. Thank you. Please go ahead, sir.
Thank you, operator. Good morning, and good afternoon, everyone, and welcome to the Atara ECTRIMS 2019 data conference call. Earlier this morning, we issued a press release reporting positive preliminary data from our ongoing Phase I trial of ATA188. This press release and the slides we will be presenting during this call, are available in the Investors & Media section of atarabio.com.
I'm joined on the call today by Dr. Pascal Touchon, President and Chief Executive Officer; Dr. AJ Joshi, Chief Medical Officer; also with us today is Dr. Lawrence Steinman,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |